Abstract:
Increased requirement for diagnostic tests has
posed a significant burden on the healthcare
systems throughout the world as the COVID-19
pandemic evolves. The recommended test at present
for a diagnosis of SARS-CoV-2 infection is the reverse
transcriptase polymerase chain reaction (RT-PCR)
performed on a relevant clinical sample. Rapid point
of care molecular assays is available for use and
these could accelerate the diagnostic process and
help triage patients at emergency settings in the
future.
